Chikungunya Fever
Recent clinical, regulatory, research and industry developments relating to this disease.
Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial with recent milestones (1 completed or reporting results).
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Zika Virus2
- Chikungunya Fever1
- Chikungunya virus1
- Communicable Diseases, Emerging1
- Dengue Virus1
- Disease Outbreaks1
- Vector Borne Diseases1
- Yellow Fever1
Leading journals2
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin1
- Frontiers in public health1
Leading researchers8
- Benyon E1
- Chala B1
- Duituturaga S1
- Guillaumot L1
- Hamde F1
- Hoy D1
- Lepers C1
- Mercier A1
Affiliations (unnormalised)1
- School of Applied Natural Science1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
An acute infection caused by a mosquito-borne alphavirus CHIKUNGUNYA VIRUS characterized by RASH; FEVER; JOINT PAINS; CONJUNCTIVITIS; MENINGOENCEPHALITIS; LYMPHOPENIA; and THROMBOCYTOPENIA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.